Today: 27 June 2026
Ferrari stock jumps on earnings beat as ‘Luce’ EV timeline comes into focus
10 February 2026
1 min read

Ferrari stock jumps on earnings beat as ‘Luce’ EV timeline comes into focus

New York, February 10, 2026, 10:32 EST — Regular session

  • Ferrari shares jumped roughly 9% following its fourth-quarter report and the release of new 2026 targets.
  • Ferrari said its order book runs through late 2027, with fresh models on deck for this year.
  • The company plans to start taking pre-orders for its “Luce” electric model in March, with the official debut set for May 25 in Rome.

Ferrari N.V. jumped 8.6% to $364.92 in early New York trading Tuesday, as investors cheered quarterly results that beat expectations. The luxury automaker also stuck to its 2026 growth guidance, fueling the rally.

This shift carries weight: the stock’s been under pressure ever since the October strategy update, which left some investors wary. Now, the company is pitching markets on stable margins, just as it approaches the debut of its first all-electric model.

Ferrari reported a 7% jump in 2025 net revenues, reaching 7.146 billion euros. Operating profit posted a steeper climb, up 12% to 2.11 billion euros. Industrial free cash flow shot up 50% to 1.538 billion euros. Shipments, though, edged down for the year—13,640 vehicles, compared to 13,752 previously.

Ferrari is projecting roughly 7.5 billion euros in revenue for 2026, aiming for a 39% EBITDA margin. For 2025, the company reported EBITDA at 2.772 billion euros, which excludes interest, tax, and non-cash expenses.

Capital returns got some attention too. Ferrari disclosed it scooped up 53,150 common shares on Euronext Milan from Feb. 2 to Feb. 6, shelling out roughly 15.1 million euros. As of Feb. 6, the carmaker’s treasury stock made up 8.71% of its issued common shares.

The product calendar is now in focus. Ferrari plans to start Luce pre-orders this March—the company’s inaugural all-electric car. CEO Benedetto Vigna called recent client feedback in San Francisco “very positive.” Reuters

Ferrari will unveil the Luce in Rome on May 25. The automaker now targets a 2030 lineup split: 40% combustion, 40% hybrid, and 20% fully electric—dialing back an earlier, more aggressive EV goal.

Ferrari’s comments on pricing and costs are also drawing investor attention, with the sector navigating changes in trade policy and figuring out the math on luxury EVs. The company insists that careful control of production underpins its pricing strength—though the arrival of new tech puts that claim under the microscope.

“Discipline” remains a recurring theme in Vigna’s recent comments to investors, as the company faces questions over looming U.S. tariff risks and analysts continue to puzzle over the timeline for ultra-luxury buyers to shift to battery-only cars. Financial Times

Even with today’s surge, there’s pressure. If buyers don’t stick around, rallies sparked by guidance can unravel—especially when investors think the price already assumes another flawless year.

Coming up: March pre-orders open for the Luce. Then there’s the model premiere in Rome on May 25, and Ferrari’s next earnings report lands May 5.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Wait 90 Days Before Buying More SpaceX Stock Due to Upcoming Share Unlocks
    June 27, 2026, 12:00 PM EDT. Space Exploration Technologies (SpaceX) recently made a record-breaking $75 billion initial public offering (IPO), valuing the company at $1.77 trillion. Although its stock briefly surged, it has dropped 3% since debut. Investors should consider waiting 90 days before buying more shares due to an upcoming lockup period, during which insiders are restricted from selling. After this period, additional shares will enter the market, potentially pressuring the stock price downward. SpaceX only floated about 4% of shares initially, with gradual increases expected over time. Historically, blockbuster IPOs often underperform in their first years, so patience and reassessment after the lockup expiration in September is advised to gauge true market response and valuation.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop